Multi-omics integration identifies a selective vulnerability of colorectal cancer subtypes to YM155

Tumor heterogeneity is a major challenge to the treatment of colorectal cancer (CRC). Recently, a transcriptome-based classification was developed, segregating CRC into four consensus molecular subtypes (CMS) with distinct biological and clinical characteristics. Here, we applied the CMS classificat...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhan, Tianzuo (Author) , Faehling, Verena (Author) , Rauscher, Benedikt (Author) , Betge, Johannes (Author) , Ebert, Matthias (Author) , Boutros, Michael (Author)
Format: Article (Journal)
Language:English
Published: 15 April 2021
In: International journal of cancer
Year: 2021, Volume: 148, Issue: 8, Pages: 1948-1963
ISSN:1097-0215
DOI:10.1002/ijc.33393
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/ijc.33393
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.33393
Get full text
Author Notes:Tianzuo Zhan, Verena Faehling, Benedikt Rauscher, Johannes Betge, Matthias P. Ebert, Michael Boutros

MARC

LEADER 00000caa a2200000 c 4500
001 1767116217
003 DE-627
005 20231114133520.0
007 cr uuu---uuuuu
008 210816s2021 xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.33393  |2 doi 
035 |a (DE-627)1767116217 
035 |a (DE-599)KXP1767116217 
035 |a (OCoLC)1341420679 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Zhan, Tianzuo  |d 1985-  |e VerfasserIn  |0 (DE-588)1019998911  |0 (DE-627)691070105  |0 (DE-576)359019544  |4 aut 
245 1 0 |a Multi-omics integration identifies a selective vulnerability of colorectal cancer subtypes to YM155  |c Tianzuo Zhan, Verena Faehling, Benedikt Rauscher, Johannes Betge, Matthias P. Ebert, Michael Boutros 
264 1 |c 15 April 2021 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.08.2021 
520 |a Tumor heterogeneity is a major challenge to the treatment of colorectal cancer (CRC). Recently, a transcriptome-based classification was developed, segregating CRC into four consensus molecular subtypes (CMS) with distinct biological and clinical characteristics. Here, we applied the CMS classification on CRC cell lines to identify novel subtype-specific drug vulnerabilities. We combined publicly available transcriptome data from multiple resources to assign 157 CRC cell lines to CMS. By integrating results from large-scale drug screens, we discovered that the CMS1 subtype is highly vulnerable to the BIRC5 suppressor YM155. We confirmed our results using an independent panel of CRC cell lines and demonstrated a 100-fold higher sensitivity of CMS1. This vulnerability was specific to YM155 and not observed for commonly used chemotherapeutic agents. In CMS1 CRC, low concentrations of YM155 induced apoptosis and expression signatures associated with ER stress-mediated apoptosis signaling. Using a genome-wide CRISPR/Cas9 screen, we further discovered a novel role of genes involved in LDL-receptor trafficking as modulators of YM155 sensitivity in the CRC cell line HCT116. Our work shows that combining drug response data with CMS classification in cell lines can reveal selective vulnerabilities and proposes YM155 as a novel subtype-specific drug. 
650 4 |a colorectal cancer 
650 4 |a consensus molecular subtypes 
650 4 |a CRISPR 
650 4 |a drug screening 
650 4 |a YM155 
700 1 |a Faehling, Verena  |d 1996-  |e VerfasserIn  |0 (DE-588)1309852588  |0 (DE-627)1870245733  |4 aut 
700 1 |a Rauscher, Benedikt  |d 1990-  |e VerfasserIn  |0 (DE-588)115648877X  |0 (DE-627)1019302666  |0 (DE-576)502212357  |4 aut 
700 1 |a Betge, Johannes  |d 1986-  |e VerfasserIn  |0 (DE-588)108257421X  |0 (DE-627)847674347  |0 (DE-576)455525021  |4 aut 
700 1 |a Ebert, Matthias  |d 1968-  |e VerfasserIn  |0 (DE-588)1030133522  |0 (DE-627)734827083  |0 (DE-576)377938432  |4 aut 
700 1 |a Boutros, Michael  |e VerfasserIn  |0 (DE-588)1023031132  |0 (DE-627)717350045  |0 (DE-576)366291831  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 148(2021), 8, Seite 1948-1963  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a Multi-omics integration identifies a selective vulnerability of colorectal cancer subtypes to YM155 
773 1 8 |g volume:148  |g year:2021  |g number:8  |g pages:1948-1963  |g extent:16  |a Multi-omics integration identifies a selective vulnerability of colorectal cancer subtypes to YM155 
856 4 0 |u https://doi.org/10.1002/ijc.33393  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.33393  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210816 
993 |a Article 
994 |a 2021 
998 |g 1023031132  |a Boutros, Michael  |m 1023031132:Boutros, Michael  |d 60000  |e 60000PB1023031132  |k 0/60000/  |p 6  |y j 
998 |g 1030133522  |a Ebert, Matthias  |m 1030133522:Ebert, Matthias  |d 60000  |d 61100  |e 60000PE1030133522  |e 61100PE1030133522  |k 0/60000/  |k 1/60000/61100/  |p 5 
998 |g 108257421X  |a Betge, Johannes  |m 108257421X:Betge, Johannes  |d 60000  |d 61100  |e 60000PB108257421X  |e 61100PB108257421X  |k 0/60000/  |k 1/60000/61100/  |p 4 
998 |g 1309852588  |a Faehling, Verena  |m 1309852588:Faehling, Verena  |d 50000  |e 50000PF1309852588  |k 0/50000/  |p 2 
998 |g 1019998911  |a Zhan, Tianzuo  |m 1019998911:Zhan, Tianzuo  |d 60000  |d 61100  |e 60000PZ1019998911  |e 61100PZ1019998911  |k 0/60000/  |k 1/60000/61100/  |p 1  |x j 
999 |a KXP-PPN1767116217  |e 3969354242 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 16.08.2021"],"relHost":[{"title":[{"subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title_sort":"International journal of cancer","title":"International journal of cancer"}],"origin":[{"publisherPlace":"Bognor Regis","dateIssuedKey":"1966","dateIssuedDisp":"1966-","publisher":"Wiley-Liss"}],"titleTranslated":[{"translated":"Journal international du cancer"}],"corporate":[{"display":"International Union against Cancer","role":"isb"}],"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"id":{"eki":["269532781"],"issn":["1097-0215"],"doi":["10.1002/(ISSN)1097-0215"],"zdb":["1474822-8"]},"part":{"year":"2021","pages":"1948-1963","text":"148(2021), 8, Seite 1948-1963","volume":"148","extent":"16","issue":"8"},"physDesc":[{"extent":"Online-Ressource"}],"titleAlt":[{"title":"Predictive oncology"}],"language":["eng"],"disp":"Multi-omics integration identifies a selective vulnerability of colorectal cancer subtypes to YM155International journal of cancer","recId":"269532781","pubHistory":["1.1966 -"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"id":{"eki":["1767116217"],"doi":["10.1002/ijc.33393"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"16 S."}],"title":[{"title_sort":"Multi-omics integration identifies a selective vulnerability of colorectal cancer subtypes to YM155","title":"Multi-omics integration identifies a selective vulnerability of colorectal cancer subtypes to YM155"}],"language":["eng"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"15 April 2021"}],"name":{"displayForm":["Tianzuo Zhan, Verena Faehling, Benedikt Rauscher, Johannes Betge, Matthias P. Ebert, Michael Boutros"]},"recId":"1767116217","person":[{"role":"aut","display":"Zhan, Tianzuo","given":"Tianzuo","family":"Zhan"},{"role":"aut","family":"Faehling","given":"Verena","display":"Faehling, Verena"},{"family":"Rauscher","given":"Benedikt","display":"Rauscher, Benedikt","role":"aut"},{"role":"aut","family":"Betge","given":"Johannes","display":"Betge, Johannes"},{"role":"aut","display":"Ebert, Matthias","given":"Matthias","family":"Ebert"},{"family":"Boutros","given":"Michael","display":"Boutros, Michael","role":"aut"}]} 
SRT |a ZHANTIANZUMULTIOMICS1520